Основные показатели сайта
| Возраст домена | n/a |
| Дата окончания | n/a |
| ИКС | n/a |
| Страниц в Google | n/a |
| Страниц в Яндексе | n/a |
| Dmoz | n/a |
| Яндекс Каталог | n/a |
| Alexa Traffic Rank | n/a |
| Alexa Country | n/a |
| История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Анализ сайта
Title
Pharmacovigilance Analytics - Your best resource for PV analytics news, content and innovation!
Keywords
n/a
Description
Latest information on pharmacovigilance analytics (PV analytics), with emphasis on new technological advances related to big data analytics, artificial intelligence, cognitive computing, data mining, text and information mining, and visualization tools, among others, and how they integrate with drug safety and pharmacovigilance.
Кодировка
UTF-8
Размер страницы
167.96 КБ
Количество слов
2 500
Длина текста на странице
84 677 симв.
Длина текста без пробелов
71 488 симв.
<H1>
- Pharmacovigilance Analytics
<H2>
- Main Content
- Analysis Of Textual Data May Complement Traditional Pharmacovigilance
- Machine Learning and Pharmacovigilance
- Post-Randomization vs On Treatment Made All the Difference
- Pharmacovigilance Audits/Inspections and PV Analytics!
- Artificial Intelligence in pharmacovigilance? What a challenge!
- Knowledge Graphs, Semantic Web and Drug Safety
- Review of Safety in FDA Medical Reviews
- Analysis of the latest review of safety sections for new drug applications (NDAs...
- Conclusions
- Mining PubMed for Drug Induced Acute Kidney Injury
- Top 7 Predictive Model Applications in Drug Safety and Pharmacovigilance
- The Pharmacovigilance of the Future: Prospective, Proactive, and Predictive
- Primary Sidebar
<H3>
- How Analytics Are Transforming Pharmacovigilance
- Second part of: Minin g PubMed for Drug Induced Acute Kidney Injury
- CDER Clinical Review Template
- Safety review approach
- Review of the safety database
- Adequacy of applicant’s clinical safety assessments
- Safety results
- Analysis of submission-specific safety issues
- Safety analysis by demographic subgroups
- Clinical outcome assessment (COA) analyses informing safety/tolerability
- Specific safety studies / clinical trials
- Additional safety explorations
- Safety in the postmarket setting
- Additional safety issues from other disciplines
- Integrated assessment of safety
- Enhancing signal detection capabilities beyond regular literature search
- Featured News / Posts
- From Nature journal
Анализ текста
- 1.52% ( 38 ) analytic
- 1.32% ( 33 ) data
- 1.28% ( 32 ) pharmacovigilance
- 1.16% ( 29 ) analysis
- 1.04% ( 26 ) that
- 0.96% ( 24 ) event
- 0.92% ( 23 ) safety
- 0.92% ( 23 ) will
- 0.80% ( 20 ) learning
- 0.80% ( 20 ) product
- 0.76% ( 19 ) from
- 0.76% ( 19 ) with
- 0.72% ( 18 ) this
- 0.68% ( 17 ) adverse
- 0.56% ( 14 ) case
- 0.52% ( 13 ) risk
- 0.48% ( 12 ) medicinal
- 0.44% ( 11 ) identification
- 0.44% ( 11 ) information
- 0.44% ( 11 ) monitoring
Идет сбор информации... Обновить
Идет сбор информации... Обновить
Идет сбор информации... Обновить
Идет сбор информации... Обновить
User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php
Sitemap: https://www.pharmacovigilanceanalytics.com/wp-sitemap.xml
IP адрес
США - 173.236.192.82
Организация
New Dream Network, LLC
Интернет провайдер
New Dream Network, LLC
HTTP/1.1 200 OK
Date: Sun, 08 Jan 2023 02:11:50 GMT
Server: Apache
Link: ; rel="https://api.w.org/"
Upgrade: h2
Connection: Upgrade
Vary: Accept-Encoding,User-Agent
Cache-Control: max-age=600
Expires: Sun, 08 Jan 2023 02:21:50 GMT
Content-Length: 171987
Content-Type: text/html; charset=UTF-8
Проиндексирован
Ссылаются
Дополнительные ссылки
Ссылка на отчет
Анализ сайта
Кнопка в Вашем браузере
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"